DHSIX
Price
$24.91
Change
-$0.17 (-0.68%)
Updated
Jan 22 closing price
Net Assets
227.98M
VISVX
Price
$49.47
Change
-$0.35 (-0.70%)
Updated
Jan 22 closing price
Net Assets
58.32B
Ad is loading...

DHSIX vs VISVX

Header iconDHSIX vs VISVX Comparison
Open Charts DHSIX vs VISVXBanner chart's image
Diamond Hill Small Cap I
Price$24.91
Change-$0.17 (-0.68%)
VolumeN/A
Net Assets227.98M
Vanguard Small Cap Value Index I
Price$49.47
Change-$0.35 (-0.70%)
VolumeN/A
Net Assets58.32B
DHSIX vs VISVX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DHSIX vs. VISVX commentary
Jan 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DHSIX is a Hold and VISVX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 58.3B vs. DHSIX (228M). DHSIX pays higher dividends than VISVX: DHSIX (2.15) vs VISVX (1.90). DHSIX was incepted earlier than VISVX: DHSIX (20 years) vs VISVX (27 years). DHSIX is a more actively managed with annual turnover of: 41.00 vs. VISVX (16.00). DHSIX has a lower initial minimum investment than VISVX: DHSIX (2500) vs VISVX (3000). VISVX annual gain was more profitable for investors over the last year : 17.36 vs. DHSIX (9.61). VISVX return over 5 years is better than : 54.31 vs. DHSIX (-11.97).
DHSIXVISVXDHSIX / VISVX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years27 years-
Gain YTD4.3574.060107%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets228M58.3B0%
Annual Yield % from dividends2.151.90113%
Returns for 1 year9.6117.3655%
Returns for 3 years-18.7024.14-77%
Returns for 5 years-11.9754.31-22%
Returns for 10 years-12.30106.95-12%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MSB30.810.67
+2.22%
Mesabi Trust
BX182.771.25
+0.69%
Blackstone
TVTX19.46N/A
N/A
Travere Therapeutics
BEP20.03-0.66
-3.19%
Brookfield Renewable Partners LP
UNCY0.62-0.03
-4.56%
Unicycive Therapeutics